Greg Whitehead

Greg Whitehead

Company: Editas Medicine

Job title: Senior Vice President, Quality


Panel Discussion: Exploring the Importance of Standardizing Collections While Maintaining Donor Diversity for a Rich Pool 1:45 pm

Standardizing donor testing methodologies globally Important criteria to consider to sustain donor diversity Gaining insight beyond the typical starting information (i.e age, sex, disease history) for more clarity on the physical attributes of the donor Using the advanced donor characteristic details to increase populations areas of interest in study design and maximize downstream clinical success…Read more

day: Day One

Exploring Regulatory Considerations for Genetic Engineering of Immune Cells & Donor-Derived Material 9:30 am - 12:00 pm

Due to the ability to treat multiple patients from one donor source, allogeneic cell therapies hold the blockbuster potential to usher in a new “future” of cell therapy, with the capacity to provide “off-the-shelf” treatments to improve the accessibility, cost of goods, and turnaround times for cell therapies. However, taking cells from donors and the…Read more

day: Pre-Conference Day

Industry Leader’s Fireside Chat: Developing a Road Map From the Donor to the Final Product 8:15 am

A panel discussion from the industry leaders of the field to set the scene on the importance of effective donor selection. Ask your questions live to understand the expert’s thoughts on key topics including: Exploring demographics: to what extent do sex, age and health status play a role in potency? Creating the ultimate donor pool…Read more

day: Day One

Chair’s Opening Remarks 8:00 am

Read more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.